Sandip Agarwala invests in mid-stage to commercial-stage biotechnology and medical device companies. See sector focus and contact routes.
Sandip Agarwala invests in mid-stage to commercial-stage biotechnology and medical device companies, focusing on structured investments including royalty transactions and revenue interests rather than traditional venture checks [1][4]. He led Longitude Capital’s creation of the royalty investment vehicle CrownWheel Partners and assembled a diversified portfolio of healthcare revenue interests [1]. While specific check sizes are not publicly disclosed, his firm targets clinically de-risked assets likely to achieve value-creating milestones within three to five years [1][4]. Notable portfolio involvement includes directorships at Tiburio Therapeutics, Opna-IO, and Opna Immuno-Oncology, reflecting his focus on life sciences credit and growth equity [5].
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Menlo Park.
Investors like Sandip Agarwala · Full investor directory · Investor access · Company funding database